|
R S S F e e d s |
|
FT.com - Drugs and Healthcare
|
FT.com - Drugs and Healthcare
|
|
-
ImClone backs $6.5bn Eli Lilly bid
The US cancer drug maker agrees a $70 a share cash offer from Eli Lilly, which trumped an unsolicited approach from ImClone's partner Bristol-Myers Squibb
-
Eli Lilly buys ImClone
Biotechnology stocks once underperformed the broader Nasdaq but have found favour as banks, brokers and insurance companies redefine a risky bet
-
United Drug eyes double-digit growth despite difficulties
United Drug, the wholesaler of pharmaceuticals and medical equipment, is poised to report double-digit earnings growth this year
-
Plan to give drug groups direct public access
The pharmaceutical sector would have greater freedom to provide information on its medicines directly to patients across Europe under proposals endorsed in a forum convened by Brussels
-
BMS faces pressure on ImClone bid
Pressure was mounting on Bristol-Myers Squibb to raise its $62 a share unsolicited offer for ImClone, the US biotech company, which said it was continuing negotiations with a second "mystery bidder"
|
|
R S S F e e d s 
